Multi-component infusion hepatoprotectors for liver damage

Por E. I. Sas, V. B. Grinevich
Publicado em 2019-05-01

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer

Por Deben, Christophe, Wouters, An, de Beeck, Ken Op, van Den Bossche, Jolien, Jacobs, Julie, Zwaenepoel, Karen, Peeters, Marc, Van Meerbeeck, Jan, Lardon, Filip, Rolfo, Christian, Deschoolmeester, Vanessa, Pauwels, Patrick
Publicado no Oncotarget (2015)

Didanosine Population Pharmacokinetics in West African Human Immunodeficiency Virus-Infected Children Administered Once-Daily Tablets in Relation to Efficacy after One Year of Trea...

Por Hirt, Déborah, Bardin, Christophe, Diagbouga, Serge, Nacro, Boubacar, Hien, Hervé, Zoure, Emmanuelle, Rouet, François, Ouiminga, Adama, Urien, Saik, Foulongne, Vincent, Van De Perre, Philippe, Tréluyer, Jean-Marc, Msellati, Philippe
Publicado em 2009

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

Por Sarno, Stefania, de Moliner, Erika, Ruzzene, Maria, Pagano, Mario A, Battistutta, Roberto, Bain, Jenny, Fabbro, Doriano, Schoepfer, Joseph, Elliott, Matthew, Furet, Pascal, Meggio, Flavio, Zanotti, Giuseppe, Pinna, Lorenzo A
Publicado em 2003

Modelaje matemático del modelo neurobiológico de las adicciones

Por Miguel Angel Mendoza, Sinuhé Muñoz-Sánchez, Mariana Alvarado-Vargas, Daniel Jiménez Álvarez, Andrea Gallegos
Publicado em 2017-06-01

On approaches to the functional restoration of salivary glands damaged by radiation therapy for head and neck cancer, with a review of related aspects of salivary gland morphology and development

Por Redman, RS
Publicado em 2008

A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

Por Pastores, Gregory M., Rosenbloom, Barry, Weinreb, Neal, Goker-Alpan, Ozlem, Grabowski, Gregory, Cohn, Gabriel M., Zahrieh, David
Publicado em 2014

FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system

Por Pereira, Felipe V., Arruda, Denise C., Figueiredo, Carlos R., Massaoka, Mariana H., Matsuo, Alisson L., Bueno, Valquiria, Rodrigues, Elaine G.
Publicado em 2013

Medication errors: problems and recommendations from a consensus meeting

Por Agrawal, Abha, Aronson, Jeffrey K, Britten, Nicky, Ferner, Robin E, de Smet, Peter A, Fialová, Daniela, Fitzgerald, Richard J, Likić, Robert, Maxwell, Simon R, Meyboom, Ronald H, Minuz, Pietro, Onder, Graziano, Schachter, Michael, Velo, Giampaolo
Publicado em 2009

Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey

Por Zuch de Zafra, Christina L, Ashkenazi, Avi, Darbonne, Walter C, Cheu, Melissa, Totpal, Klara, Ortega, Shirley, Flores, Heather, Walker, Mark D, Kabakoff, Bruce, Lum, Bert L, Mounho-Zamora, Barbara J, Marsters, Scot A, Dybdal, Noël O
Publicado no Cell Death Dis (2016)

Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment

Por Wu, Jiun-Ting, Chiu, Chien-Tung, Wei, Yu-Feng, Lai, Yung-Fa
Publicado no Clinics (Sao Paulo) (2015)

Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium

Por Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Yung, W.K. Alfred, Gilbert, Mark R., Wen, Patrick Y., Fine, Howard A., Mehta, Minesh P., DeAngelis, Lisa M., Lieberman, Frank S., Cloughesy, Timothy F., Robins, H. Ian, Abrey, Lauren E., Prados, Michael D.
Publicado em 2008

Pharmacodynamic sodium channel blockers-induced seizure aggravation in patients with newly diagnosed focal epilepsy

Por V. A. Karlov, P. N. Vlasov, A. M. Azhigova, A. B. Kozhokaru, A. S. Orlova
Publicado em 2021-08-01

Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

Por Orestes Santos-Morales, Alina Díaz-Machado, Daise Jiménez-Rodríguez, Yaisel Pomares-Iturralde, Tatiana Festary-Casanovas, Carlos A. González-Delgado, Sonia Pérez-Rodríguez, Eulalia Alfonso-Muñoz, Carmen Viada-González, Patricia Piedra-Sierra, Idrian García-García, Daniel Amaro-González, for the NeuroEPO Study Group, Julio César García-Rodríguez, Iliana Sosa-Testé, Alicia Lagarto-Parra, Laura Barrero-Viera, Marlene David-Baldo, Maura Tamayo-Rodríguez, Ivonne Rivero-Vázquez, Gricel González-Gamiz, Alis Martín-Trujillo, Yasmila Rodríguez-Fernández, Ana Alfa Ledo-de la Luz, Maylén Álvarez-Delgado, Ivón Howland-Álvarez, Yolanda Cruz-Gómez
Publicado em 2017-07-01

Pronóstico de la epilepsia. Inicio del tratamiento crónico farmacológico

Por J.M. Mercadé Cerdá, J.A. Mauri Llerda, J.L. Becerra Cuñat, J. Parra Gomez, A. Molins Albanell, C. Viteri Torres, F.J. López Gonzalez, X. Salas Puig
Publicado em 2015-07-01

Brain, body and machine Proceedings of an International Symposium on the Occasion of the 25th Anniversary of McGill University Centre for Intelligent Machines /

Por Angeles, Jorge., Boulet, Benoit., Clark, James J., Kovecses, Jozsef., Siddiqi, Kaleem.
Publicado em 2010

HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent

Por Qiao, Jingjuan, Li, Shunyi, Wei, Lixia, Jiang, Jie, Long, Robert, Mao, Hui, Wei, Ling, Wang, Liya, Yang, Hua, Grossniklaus, Hans E., Liu, Zhi-Ren, Yang, Jenny J.
Publicado em 2011

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice

Por Xiaowan Wang, Runmin Song, Wenliang Lu, Wenliang Lu, Ziyu Liu, Lichun Wang, Xiaojuan Zhu, Yanjun Liu, Zijie Sun, Jiang Li, Xiaomeng Li
Publicado em 2017-05-01

Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers

Por Radicioni M, Castiglioni C, Giori A, Cupone I, Frangione V, Rovati S
Publicado em 2017-04-01

Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles

Por Somvadee Laohavaleeson, Karen Lolans, John P Quinn, Joseph L Kuti, David P Nicolau
Publicado em 2008-11-01